The final consensus maps for both complexes had resolutions of 3.0 , enabling confident modelling of all the major features of the complexes
Neuropsychiatric adverse events associated with glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA adverse event reporting system database[J]
(2023) 14:1070264.doi: 10.3389/fendo.2023.1070264 Summary Keywords ferroptosis, polycystic ovary syndrome, oxidative stress, metabolic disorders, expression, biomarkers Citation Wang M, Zhang B-Q, Ma S, Xu Y, Zhao D-H, Zhang J-S, Li C-J, Zhou X and Zheng L-W (2024) Broadening horizons: the role of ferroptosis in polycystic ovary syndrome
Future studies with long-term treatment would be helpful to determine whether chronic MC4R agonism may result in the formation of new pro-social structural changes or even lead to reversal of existing structural abnormalities